These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34411293)

  • 1. IL-33 activates mTORC1 and modulates glycolytic metabolism in CD8
    Liang Y; Wang X; Wang H; Yang W; Yi P; Soong L; Cong Y; Cai J; Fan X; Sun J
    Immunology; 2022 Jan; 165(1):61-73. PubMed ID: 34411293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prosurvival IL-7-Stimulated Weak Strength of mTORC1-S6K Controls T Cell Memory via Transcriptional FOXO1-TCF1-Id3 and Metabolic AMPKα1-ULK1-ATG7 Pathways.
    Xu A; Leary SC; Islam MF; Wu Z; Bhanumathy KK; Ara A; Chibbar R; Fleywald A; Ahmed KA; Xiang J
    J Immunol; 2022 Jan; 208(1):155-168. PubMed ID: 34872976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
    McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
    Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.
    Finlay DK; Rosenzweig E; Sinclair LV; Feijoo-Carnero C; Hukelmann JL; Rolf J; Panteleyev AA; Okkenhaug K; Cantrell DA
    J Exp Med; 2012 Dec; 209(13):2441-53. PubMed ID: 23183047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DAPK1 (death associated protein kinase 1) mediates mTORC1 activation and antiviral activities in CD8
    Wei Z; Li P; He R; Liu H; Liu N; Xia Y; Bi G; Du Q; Xia M; Pei L; Wang J; Wang G; Tang ZH; Cheng X; Li H; Li Z; Ye L; Laurence A; Lu Y; Yang XP
    Cell Mol Immunol; 2021 Jan; 18(1):138-149. PubMed ID: 31541182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signaling.
    D'Souza AD; Parish IA; McKay SE; Kaech SM; Shadel GS
    Am J Pathol; 2011 Jun; 178(6):2740-51. PubMed ID: 21641396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17RA-Signaling Modulates CD8+ T Cell Survival and Exhaustion During
    Tosello Boari J; Araujo Furlan CL; Fiocca Vernengo F; Rodriguez C; Ramello MC; Amezcua Vesely MC; Gorosito Serrán M; Nuñez NG; Richer W; Piaggio E; Montes CL; Gruppi A; Acosta Rodríguez EV
    Front Immunol; 2018; 9():2347. PubMed ID: 30364284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulators of Glucose Metabolism in CD4
    Palmer CS; Hussain T; Duette G; Weller TJ; Ostrowski M; Sada-Ovalle I; Crowe SM
    Int Rev Immunol; 2016 Nov; 35(6):477-488. PubMed ID: 26606199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acids and RagD potentiate mTORC1 activation in CD8
    Zhang Y; Hu H; Liu W; Yan SM; Li Y; Tan L; Chen Y; Liu J; Peng Z; Yuan Y; Huang W; Yu F; He X; Li B; Zhang H
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33883257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The deubiquitinase Otub1 controls the activation of CD8
    Zhou X; Yu J; Cheng X; Zhao B; Manyam GC; Zhang L; Schluns K; Li P; Wang J; Sun SC
    Nat Immunol; 2019 Jul; 20(7):879-889. PubMed ID: 31182807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-36β Promotes CD8
    Zhao X; Chen X; Shen X; Tang P; Chen C; Zhu Q; Li M; Xia R; Yang X; Feng C; Zhu X; Zhu Y; Sun Z; Zhang X; Lu B; Wang X
    Front Immunol; 2019; 10():1803. PubMed ID: 31447838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Profiling Using Stable Isotope Tracing Reveals Distinct Patterns of Glucose Utilization by Physiologically Activated CD8
    Ma EH; Verway MJ; Johnson RM; Roy DG; Steadman M; Hayes S; Williams KS; Sheldon RD; Samborska B; Kosinski PA; Kim H; Griss T; Faubert B; Condotta SA; Krawczyk CM; DeBerardinis RJ; Stewart KM; Richer MJ; Chubukov V; Roddy TP; Jones RG
    Immunity; 2019 Nov; 51(5):856-870.e5. PubMed ID: 31747582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTORC1 signaling in antigen-presenting cells of the skin restrains CD8
    Pelgrom LR; Patente TA; Otto F; Nouwen LV; Ozir-Fazalalikhan A; van der Ham AJ; van der Zande HJP; Heieis GA; Arens R; Everts B
    Cell Rep; 2022 Jul; 40(1):111032. PubMed ID: 35793635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy.
    Wang C; Edilova MI; Wagar LE; Mujib S; Singer M; Bernard NF; Croughs T; Lederman MM; Sereti I; Fischl MA; Kremmer E; Ostrowski M; Routy JP; Watts TH
    J Immunol; 2018 Jan; 200(2):558-564. PubMed ID: 29222166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8 T cell responses to lymphocytic choriomeningitis virus in early growth response gene 1-deficient mice.
    Singh A; Svaren J; Grayson J; Suresh M
    J Immunol; 2004 Sep; 173(6):3855-62. PubMed ID: 15356133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose availability regulates IFN-gamma production and p70S6 kinase activation in CD8+ effector T cells.
    Cham CM; Gajewski TF
    J Immunol; 2005 Apr; 174(8):4670-7. PubMed ID: 15814691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of mTORC1 at late endosomes misdirects T cell fate decision in older individuals.
    Jin J; Kim C; Xia Q; Gould TM; Cao W; Zhang H; Li X; Weiskopf D; Grifoni A; Sette A; Weyand CM; Goronzy JJ
    Sci Immunol; 2021 Jun; 6(60):. PubMed ID: 34145066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costimulation Endows Immunotherapeutic CD8 T Cells with IL-36 Responsiveness during Aerobic Glycolysis.
    Tsurutani N; Mittal P; St Rose MC; Ngoi SM; Svedova J; Menoret A; Treadway FB; Laubenbacher R; Suárez-Ramírez JE; Cauley LS; Adler AJ; Vella AT
    J Immunol; 2016 Jan; 196(1):124-34. PubMed ID: 26573834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
    Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
    J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Glut1 and Glucose Metabolism by Decreased Akt/mTORC1 Signaling Drives T Cell Impairment in B Cell Leukemia.
    Siska PJ; van der Windt GJ; Kishton RJ; Cohen S; Eisner W; MacIver NJ; Kater AP; Weinberg JB; Rathmell JC
    J Immunol; 2016 Sep; 197(6):2532-40. PubMed ID: 27511728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.